Bio-Rad Laboratories, Inc. (BIO) vs Solventum Corporation (SOLV)

SOLV leads on 11 of 12 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Bio-Rad Laboratories, Inc. logo
BIO
Bio-Rad Laboratories, Inc.
$7.73B
$285.94Healthcare
Solventum Corporation logo
SOLV
Solventum Corporation
$13.66B
$78.87Healthcare

Total return — BIO vs SOLV

growth of $100 · last 2y
BIO -16.2%SOLV -1.4%SOLV compounded faster
60708090100110Start $10020252026$84$99
BIO SOLV

BIO vs SOLV: by the numbers

  • •SOLV is the larger company ($13.66B vs $7.73B market cap).
  • •SOLV trades at the lower earnings multiple (9.65 vs 47.11 P/E).
  • •SOLV converts more revenue to profit (17.33% vs 6.52% net margin).
  • •SOLV grew revenue faster over the past five years (2.72% vs -0.84% CAGR).

Which is better, BIO or SOLV?

Metric tally: BIO 1 · SOLV 11

It depends on what you're optimizing for:

ValueSOLV(lower P/E)
GrowthSOLV(faster 5Y revenue CAGR)
QualitySOLV(higher ROIC)

Valuation

MetricBIOSOLV
P/E ratio47.119.65●
Forward P/E28.6911.17●
P/S ratio2.981.68●
P/B ratio1.13●2.79
PEG ratio—0.04
EV / EBITDA18.276.67●
FCF yield4.63%—

Profitability

MetricBIOSOLV
Gross margin51.87%53.67%●
Operating margin9.25%25.54%●
Net margin6.52%17.33%●
ROE2.46%28.82%●
ROIC2.04%17.76%●

Growth (annualized)

MetricBIOSOLV
Revenue CAGR (5Y)-0.84%2.72%●
EPS CAGR (5Y)-26.27%6.26%●
FCF CAGR (5Y)-7.57%—
Total return CAGR (5Y)-13.82%—

Frequently asked

Which is better, BIO or SOLV?
It depends on your goal. value: SOLV (lower P/E); growth: SOLV (faster 5Y revenue CAGR); quality: SOLV (higher ROIC). Across all compared metrics, SOLV leads 11 to 1.
Is BIO or SOLV cheaper?
On trailing earnings, SOLV is cheaper: BIO trades at a 47.11 P/E and SOLV at 9.65.
Which has grown faster, BIO or SOLV?
Over the past five years, SOLV grew revenue faster — BIO at a -0.84% CAGR versus SOLV at 2.72%.
Is BIO or SOLV more profitable?
SOLV runs the higher net margin — BIO at 6.52% versus SOLV at 17.33%.

Go deeper

Full BIO analysisFull SOLV analysisInteractive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratioSolventum P/E ratioBio-Rad Laboratories dividend yieldSolventum dividend yieldBio-Rad Laboratories ROESolventum ROEBio-Rad Laboratories operating marginSolventum operating marginBio-Rad Laboratories revenue growthSolventum revenue growthBio-Rad Laboratories free cash flowSolventum free cash flow

Bio-Rad Laboratories & Solventum appear in these rankings

Highest ROE StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.